Rationale and design of STOP DVT study: Rosuvastatin for the prevention of deep vein thrombosis in patients undergoing total knee replacement arthroplasty - A prospective randomized open-label controlled trial

Contemporary Clinical Trials

Volumn 32, Issue 5, 2011, Pages 779-782

  Park, Woo Jung ^a   Jo, Sang Ho ^a   Kim, Sung Ai ^a   Kim, Hyun Sook ^a   Han, Sang Jin ^a   Choi, Young Jin ^b   Rhim, Chong Yun ^a  

^a Hallym University Sacred Heart Hospital   (South Korea)

^b Hallym University   (South Korea)

Author keywords

Deep vein thrombosis; Orthopedic surgery; Prevention; Randomized controlled trial; Statin

Indexed keywords

ENOXAPARIN; ROSUVASTATIN;

AGING; ANTICOAGULANT THERAPY; ARTICLE; COMORBIDITY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG MEGADOSE; HEPARINIZATION; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; OPEN STUDY; PERIOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STUDY DESIGN; TOTAL KNEE REPLACEMENT; TREATMENT DURATION; TREATMENT OUTCOME;

ARTHROPLASTY, REPLACEMENT, KNEE; DRUG THERAPY, COMBINATION; ENOXAPARIN; FLUOROBENZENES; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; ORTHOPEDIC PROCEDURES; PYRIMIDINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RISK ASSESSMENT; SAMPLE SIZE; SULFONAMIDES; VENOUS THROMBOSIS;

EID: 79960891389     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2011.06.001     Document Type: Article

References (16)

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study. Lancet 1994, 344(4S):1383-1389.
2. Shepherd J., Cobbe S.M., Ford I., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995, 333:1301-1307.
3. Tonkin A.M., Colquhoun D., Emberson J., et al. Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study. Lancet 2000, 356:1871-1875.
4. Ridker P.M., Danielson E., Fonseca F.A., et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008, 359:2195-2207.
5. Aberg M., Johnell M., Wickstrom M., et al. Simvastatin reduces the production of prothrombotic prostasomes in human prostate cancer cells. Thromb Haemost 2008, 100:655-662.
6. Undas A., Brummel-Ziedins K.E., Mann K.G. Statins and blood coagulation. Arterioscler Thromb Vasc Biol 2005, 25:287-294.
7. Ramcharan A.S., Van Stralen K.J., Snoep J.D., et al. HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis. J Thromb Haemost 2009, 7:514-520.
8. Agarwal V., Phung O.J., Tongbram V., et al. Statin use and the prevention of venous thromboembolism: a meta-analysis. Int J Clin Pract 2010, 64:1375-1383.
9. Glynn R.J., Danielson E., Fonseca F.A., et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med 2009, 360:1851-1861.
10. Bergqvist D., Benoni G., Bjorgell O., et al. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 1996, 335:696-700.
11. Geerts W.H., Bergqvist D., Pineo G.F., et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133(6 suppl):381S-453S.
12. Undas A., Brummel-Ziedins K.E., Potaczek D.P., et al. Atorvastatin and quinapril inhibit blood coagulation in patients with coronary artery disease following 28days of therapy. J Thromb Haemost 2006, 4:2397-2404.
13. Szczeklik A., Musial J., Undas A., et al. Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia. J Am Coll Cardiol 1999, 33:1286-1293.
14. Jerjes-Sanchez C. Venous and arterial thrombosis: a continuous spectrum of the same disease?. Eur Heart J 2005, 26:3-4.
15. Agnelli G., Becattini C. Venous thromboembolism and atherosclerosis: common denominators or different diseases?. J Thromb Haemost 2006, 4:1886-1890.
16. Kyrle P.A., Rosendaal F.R., Eichinger S. Risk assessment for recurrent venous thrombosis. Lancet 2010, 376:2032-2039.